Posted Aug. 2, 2017 at 12:44 p.m.

Premium Lock Well-known biotech investor buys 6.8 percent stake in Durham-based Dova Pharmaceuticals

Published: 2017-08-02 12:44:20
Updated: 2017-08-02 12:44:20

Dova Pharmaceuticals Dova Pharmaceuticals

Dova went public in late June. The company was formed in March 2016 and has produced no revenue. It posted a loss of $27.2 million in 2016 and a loss of $5.4 million in the first three months of 2017....

Read More
Read More

WRAL TechWire any time: Twitter, Facebook

Copyright 2017 The University of North Carolina at Chapel Hill. All rights reserved.
Editor's Blog

Editor's Blog

The latest blog posts from our WRAL TechWire and WRAL editors. Read more articles…

Please Log In to add a comment.

Latest for Insiders